pyrazines has been researched along with Brain Emboli in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buller, B; Chopp, M; Jiang, J; Jiang, Y; Liu, X; Morris, D; Zhang, L; Zhang, ZG; Zhao, D | 1 |
| Bouley, J; Fisher, M; Henninger, N; Sicard, KM; Stagliano, NE | 1 |
| Chopp, M; Hozeska, A; Liu, X; Lu, M; Riordan, W; Stagliano, N; Zhang, L; Zhang, ZG | 1 |
3 other study(ies) available for pyrazines and Brain Emboli
| Article | Year |
|---|---|
Combination treatment with VELCADE and low-dose tissue plasminogen activator provides potent neuroprotection in aged rats after embolic focal ischemia.
Topics: Aging; Animals; Boronic Acids; Bortezomib; Brain Ischemia; Drug Administration Schedule; Drug Therapy, Combination; Intracranial Embolism; Male; Neuroprotective Agents; Protease Inhibitors; Pyrazines; Rats; Rats, Wistar; Tissue Plasminogen Activator | 2010 |
The proteasome inhibitor VELCADE reduces infarction in rat models of focal cerebral ischemia.
Topics: Animals; Boronic Acids; Bortezomib; Brain Infarction; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; Intracranial Embolism; Male; Neuroprotective Agents; Proteasome Inhibitors; Pyrazines; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley | 2006 |
Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
Topics: Animals; Anti-Inflammatory Agents; Boronic Acids; Bortezomib; Brain; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Intracranial Embolism; Male; NF-kappa B; Nitric Oxide Synthase Type III; Platelet Aggregation; Protease Inhibitors; Pyrazines; Rats; Rats, Wistar; Recombinant Proteins; Stroke; Time Factors; Tissue Plasminogen Activator; Vascular Patency | 2006 |